The Stone Centre at Vancouver General Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wong, Victor
NCT04501614 / 2019-002549-39: A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Terminated
1/2
11
Europe, US, RoW
Ponatinib, Chemotherapy Agents
Takeda, Takeda Development Center Americas, Inc.
Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL)
12/23
07/24
NCT03924362: Bilateral Percutaneous Nephrolithomy

Recruiting
N/A
92
Canada
PCNL
University of British Columbia
Nephrolithiasis of Both Kidneys
12/23
12/23
SOUND, NCT05701098: Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

Recruiting
N/A
116
Canada, US
Break Wave extracorporeal lithotripsy
SonoMotion
Kidney Stone, Urolithiasis, Nephrolithiasis, Renal Calculi, Kidney Calculi, Nephrolith, Urinary Calculi
12/24
01/25
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift

Recruiting
N/A
206
Europe, US
iTind, UroLift
Olympus Corporation of the Americas
Benign Prostatic Hyperplasia (BPH)
12/25
12/30
Forbes, Connor
SOUND, NCT05701098: Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

Recruiting
N/A
116
Canada, US
Break Wave extracorporeal lithotripsy
SonoMotion
Kidney Stone, Urolithiasis, Nephrolithiasis, Renal Calculi, Kidney Calculi, Nephrolith, Urinary Calculi
12/24
01/25
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift

Recruiting
N/A
206
Europe, US
iTind, UroLift
Olympus Corporation of the Americas
Benign Prostatic Hyperplasia (BPH)
12/25
12/30

Download Options